Rx Safes committed to meet the listing requirements for the Nasdaq Capital Markets: CEO
Rx Safes will be presenting at the Sidoti Spring 2016 Emerging Growth Convention in New York City later this month.
The convention connects management teams from companies with a market cap of less than $600 million with small and micro-cap institutional investors, equity research analysts, investment bankers, private equity professionals and media to promote awareness in the investment community.
Rx Safes engineers and markets fingerprint-based medical devices and security storage solutions to manage and secure the use of controlled substances at the patient and consumer level.
Lorraine Yarde, Rx Safes’ CEO, is scheduled to deliver a presentation at 8:30 am (EST) on March 31. The company will also be available to meet with conference attendees and institutional investors throughout the day.
“Rx Safes’ participation in the conference is a valuable opportunity to introduce the company, our strategy and overall value proposition to the investment community,” commented Yarde. “We remain committed to capitalize and structure the Company to meet the listing requirements for the Nasdaq Capital Markets.”
The conference will feature about 80 public companies, with past attendance exceeding 475 investors.